An easily adaptable validated risk score predicts cancer-specific survival in stage II colon cancer.
Heervä E, Väliaho V, Salminen T, Nieminen L, Carpelan A, Kurki S, Sundström J, Huhtinen H, Rantala A, Carpén O, Minn H, Österlund P, Ålgars A, Ristamäki R.
Heervä E, et al. Among authors: sundstrom j.
Acta Oncol. 2020 Dec;59(12):1503-1507. doi: 10.1080/0284186X.2020.1831062. Epub 2020 Oct 12.
Acta Oncol. 2020.
PMID: 33044880
Free article.
No abstract available.